Vir Biotechnology
$33.259876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$33.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$3.45 (-9.40%) As of 1:19 PM EDT today
-$3.45 (-9.40%) Today
Why Robinhood?
You can buy or sell VIR and other stocks, options, ETFs, and crypto commission-free!
About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Read More The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Employees
229
Headquarters
San Francisco, California
Founded
2016
Market Cap
3.18B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
983.75K
High Today
$36.50
Low Today
$32.00
Open Price
$36.50
Volume
740.07K
52 Week High
$75.00
52 Week Low
$11.65
Collections
VIR Earnings
-$4.60
-$3.07
-$1.53
$0.00
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Jun 29, After Hours